Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 41,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $168.79 Daily Weekly Monthly
20 Day Moving Average: 1,020,536 shares
Shares Outstanding: 80.76 (millions)
Market Capitalization: $13,630.95 (millions)
Beta: 1.22
52 Week High: $231.89
52 Week Low: $125.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.36% -12.81%
12 Week 5.69% -1.70%
Year To Date -19.51% -30.91%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN 18,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer and Director
Ciaran Murray - Chair and Director
Barry Balfe - Chief Operating Officer
Nigel Clerkin - Chief Financial Officer
Ronan Murphy - Lead Independent Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (COR)
ICON PLC (GBCS)
ICON PLC (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/18/26
Share - Related Items
Shares Outstanding: 80.76
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.22
Market Capitalization: $13,630.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $12.49 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 4.38% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/18/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.51
Trailing 12 Months: 13.52
PEG Ratio: 3.09
Price Ratios
Price/Book: 1.46
Price/Cash Flow: 8.42
Price / Sales: 1.68
EPS Growth
vs. Year Ago Period: -12.11%
vs. Previous Quarter: -10.44%
Sales Growth
vs. Year Ago Period: 0.63%
vs. Previous Quarter: 1.26%
ROE
09/30/25 - 10.58
06/30/25 - 10.95
03/31/25 - 11.46
ROA
09/30/25 - 6.01
06/30/25 - 6.23
03/31/25 - 6.49
Current Ratio
09/30/25 - 1.06
06/30/25 - 1.29
03/31/25 - 1.27
Quick Ratio
09/30/25 - 1.06
06/30/25 - 1.29
03/31/25 - 1.27
Operating Margin
09/30/25 - 12.38
06/30/25 - 12.98
03/31/25 - 13.42
Net Margin
09/30/25 - 7.40
06/30/25 - 9.82
03/31/25 - 9.25
Pre-Tax Margin
09/30/25 - 7.67
06/30/25 - 10.11
03/31/25 - 10.10
Book Value
09/30/25 - 115.59
06/30/25 - 118.32
03/31/25 - 117.65
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - 0.31
06/30/25 - 0.35
03/31/25 - 0.36
Debt-to-Capital
09/30/25 - 23.57
06/30/25 - 26.16
03/31/25 - 26.30
 

Powered by Zacks Investment Research ©